TrianecT
TrianecT develops StrokePointer, a portable EEG device that detects stroke severity in ambulances. The technology combines brain activity measurement through a proprietary headset with AI to diagnose Large Vessel Occlusion (LVO) strokes. Detection of an LVO stroke in the ambulance will allow patients to be immediately transported to a stroke center for timely treatment, to […]
Skyline Dx
Skyline Dx is a molecular diagnostics company focusing on oncology and infectious diseases. Their platform-agnostic tests range from PCR to Next Generation Sequencing technologies. Skyline Dx partners with discovery and commercial companies to develop and distribute their diagnostic tests. The company is dedicated to advancing precision medicine through innovative molecular diagnostics.
PsyPhy
PsyPhy offers the PsyPhy Mobile Lab (PML), a comprehensive solution for recording neural activity and conducting behavioral research. The PML includes hardware, software, and subscription-based support for data analysis and education. PsyPhy aims to revolutionize neurophysiological education with accessible, high-quality equipment. The company addresses emerging markets for portable EEG and GSR devices.
PrimaGen
PrimaGen Holding focuses on developing molecular diagnostic tests and investing in bio- and medtech startups. The company generates revenues through the licensing of their diagnostics technology. PrimaGen Holding’s portfolio includes investments in PulseCath and Akkolens International.
Ellogon.ai
Ellogon’s AI-driven cancer diagnostics solution quantifies oncology biomarkers in complex histopathological slides with limited annotations. Traditional supervised deep learning requires exhaustive annotation by pathologists, which is impractical due to the enormous size and complexity of histopathology slides. Ellogon however, uses sparse-shot learning to achieve high accuracy with significantly fewer annotations, making it a game-changer in […]
CRCbioscreen
Innovating colorectal cancer screening, CRCbioscreen develops stool-based tests to detect high-risk precursor lesions. Their research, led by experts from the Netherlands Cancer Institute and based on Amsterdam UMC technology, aims to improve early cancer detection. CRCbioscreen’s tests could potentially replace current national screening programs. The company is committed to advancing oncology diagnostics through innovative biomarker […]
AI Biomics
Revolutionizing microbiome analysis, AIBiomics utilizes AI-driven image analysis to provide rapid, non-invasive stool sample diagnostics. They aim to offers quick and reliable microbial composition analysis using a smartphone camera. This innovative approach simplifies gut health monitoring, making it accessible and painless.
